Table IV.
Analyte | ICC | 95%lo | 95%Hi | CVB | CVW | CVA | |||
---|---|---|---|---|---|---|---|---|---|
Vitamins and micronutrients | |||||||||
Retinol | 90.96 | 6.11 | 2.93 | 0.98 | 0.95 | 0.98 | 21.26 | 5.51 | 3.82 |
δ-Tocopherol | 16.50 | 78.33 | 5.17 | 0.76 | 0.65 | 0.84 | 52.01 | 113.31 | 29.11 |
γ-Tocopherol | 67.62 | 31.58 | 3.00 | 0.99 | 0.98 | 0.99 | 27.59 | 18.85 | 3.00 |
α-Tocopherol* | 73.36 | 24.33 | 2.31 | 0.97 | 0.95 | 0.98 | 6.65 | 3.83 | 1.18 |
Lutein | 80.71 | 16.60 | 2.70 | 0.97 | 0.95 | 0.98 | 22.35 | 10.14 | 4.09 |
β-Cryptoxanthine* | 92.72 | 6.84 | 0.44 | 1.00 | 0.99 | 1.00 | 19.73 | 5.36 | 1.36 |
β-Carotene* | 93.52 | 4.18 | 2.30 | 0.98 | 0.96 | 0.98 | 48.36 | 10.23 | 7.58 |
Lycopene* | 67.93 | 27.93 | 4.14 | 0.94 | 0.91 | 0.96 | 47.90 | 30.72 | 11.82 |
Vitamin C* | 51.31 | 44.09 | 4.59 | 0.92 | 0.87 | 0.95 | 25.75 | 23.87 | 7.71 |
Lipids and lipid peroxides | |||||||||
TBARS* | 49.83 | 38.80 | 11.37 | 0.81 | 0.72 | 0.88 | 30.19 | 26.64 | 14.42 |
13-HODE | 14.23 | 84.43 | 1.34 | 0.91 | 0.87 | 0.95 | 21.95 | 53.45 | 6.73 |
9-HODE† | 38.38 | 60.56 | 1.07 | 0.97 | 0.96 | 0.98 | 32.76 | 41.16 | 5.46 |
13-HPODE*† | 33.49 | 54.16 | 12.35 | 0.97 | 0.96 | 0.98 | 31.92 | 40.59 | 19.38 |
9- HPODE† | 34.14 | 64.39 | 1.47 | 0.96 | 0.93 | 0.97 | 56.14 | 77.10 | 11.67 |
Linoleic acid* | 88.60 | 5.45 | 5.95 | 0.94 | 0.90 | 0.96 | 0.13 | 0.03 | 0.03 |
Plasma AOX enzymes | |||||||||
PGPX | 70.38 | 26.23 | 3.39 | 0.95 | 0.93 | 0.97 | 11.45 | 6.99 | 2.51 |
Serum AOX enzymes | |||||||||
PONa | 82.80 | 15.35 | 1.85 | 0.98 | 0.95 | 0.98 | 33.61 | 14.47 | 5.03 |
PONp* | 94.44 | 4.56 | 1.00 | 0.99 | 0.98 | 0.99 | 9.33 | 2.05 | 0.96 |
Erythrocyte AOX enzymes | |||||||||
eSOD* | 7.49 | 91.82 | 0.69 | 0.92 | 0.87 | 0.95 | 0.61 | 2.14 | 0.19 |
EGSHR* | 45.48 | 48.43 | 6.09 | 0.88 | 0.82 | 0.92 | 6.22 | 6.42 | 2.27 |
eGPX* | 80.05 | 16.85 | 3.10 | 0.96 | 0.98 | 0.98 | 5.25 | 2.41 | 1.03 |
Log-transformed to improve the approximation to a normal.
Values reported below the limit of quantitiation. For definitions see footnote for Table II.